Adaptimmune Therapeutics Plc Beta
What is the Beta of Adaptimmune Therapeutics Plc?
The Beta of Adaptimmune Therapeutics Plc is 1.44
What is the definition of Beta?
BETA indicates whether a stock is more or less volatile than the market as a whole. A beta less than 1 indicates that the stock is less volatile than the market, while a beta more than 1 indicates that the stock is more volatile. Volatility is measured as the fluctuation of the price around the mean.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta of companies in the Health Care sector on NASDAQ compared to Adaptimmune Therapeutics Plc
What does Adaptimmune Therapeutics Plc do?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Companies with beta similar to Adaptimmune Therapeutics Plc
- China Fordoo has Beta of 1.44
- National Express Plc has Beta of 1.44
- Autodesk has Beta of 1.44
- Solomon Systech (International) has Beta of 1.44
- GYG plc has Beta of 1.44
- Bavarian Nordic A/S has Beta of 1.44
- Adaptimmune Therapeutics Plc has Beta of 1.44
- VISA Steel has Beta of 1.44
- Liberty One Lithium has Beta of 1.44
- Slm Solutions Grp Z.Verk has Beta of 1.44
- Diatreme Resources has Beta of 1.44
- Rane Brake Lining has Beta of 1.44
- Black Dragon Gold has Beta of 1.44